Bull Case

Successful integration of the acquired ZimVie portfolio and cross-selling into existing dental channels lifts revenue growth above peers, while Straumann and Envista remain more exposed to slower organic demand.

Operating leverage from a steadier implant and digital workflow mix expands margins from the current ~0.9% level, narrowing the profitability gap versus Dentsply Sirona and Envista.

Debt reduction and improved cash conversion lower net leverage from 6.3x EBITDA, easing refinancing risk and improving flexibility relative to more conservatively financed peers.

A healthier procedure environment and better pricing realization support free cash flow recovery, allowing ZimVie to close the valuation discount implied by negative FCF yield versus peers.

Base Case

Revenue stabilizes as core dental demand remains mixed, with modest share gains offsetting weak macro conditions and leaving growth broadly in line with smaller medtech peers.

Margins improve only gradually because integration benefits and cost actions are partly offset by high interest expense and limited scale versus Straumann and Envista.

Leverage stays elevated near current levels, so refinancing and covenant management remain a constraint even if operating performance is steady.

Cash generation turns positive but remains uneven, keeping valuation below higher-quality peers that sustain stronger margins, lower leverage, and better conversion.

Bear Case

Weak dental procedure volumes and slower-than-expected integration keep revenue below peers, while Straumann and Envista preserve better growth through broader global reach.

Persistently thin operating margins and high interest costs leave earnings coverage strained, and the current 0.26x coverage ratio signals limited downside protection.

If refinancing costs rise or lenders demand tighter terms, leverage remains a structural drag and could force balance-sheet actions that dilute equity value.

Negative free cash flow persists, preventing deleveraging and widening the valuation gap versus peers with stronger cash generation and more resilient capital structures.

Overall Score

ZimVie’s forward path is constrained by high leverage and weak coverage, but integration-led stabilization and modest margin recovery keep the most likely outcome above bear-case levels.